camden health partners limited
camden health partners limited Company Information
Company Number
06584530
Next Accounts
Dec 2025
Shareholders
dilini kalupahana
rumisha ahmad
View AllGroup Structure
View All
Industry
General medical practice activities
Registered Address
ramsay brown llp, the brentano suite, north finchley, london, N12 8QJ
Website
www.haverstockhealth.comcamden health partners limited Estimated Valuation
Pomanda estimates the enterprise value of CAMDEN HEALTH PARTNERS LIMITED at £5.2m based on a Turnover of £7.9m and 0.66x industry multiple (adjusted for size and gross margin).
camden health partners limited Estimated Valuation
Pomanda estimates the enterprise value of CAMDEN HEALTH PARTNERS LIMITED at £503.6k based on an EBITDA of £103.1k and a 4.89x industry multiple (adjusted for size and gross margin).
camden health partners limited Estimated Valuation
Pomanda estimates the enterprise value of CAMDEN HEALTH PARTNERS LIMITED at £1.9m based on Net Assets of £770.5k and 2.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Camden Health Partners Limited Overview
Camden Health Partners Limited is a live company located in north finchley, N12 8QJ with a Companies House number of 06584530. It operates in the general medical practice activities sector, SIC Code 86210. Founded in May 2008, it's largest shareholder is dilini kalupahana with a 14.3% stake. Camden Health Partners Limited is a established, mid sized company, Pomanda has estimated its turnover at £7.9m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Camden Health Partners Limited Health Check
Pomanda's financial health check has awarded Camden Health Partners Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 2 areas for improvement. Company Health Check FAQs
6 Strong
3 Regular
2 Weak
Size
annual sales of £7.9m, make it larger than the average company (£2m)
- Camden Health Partners Limited
£2m - Industry AVG
Growth
3 year (CAGR) sales growth of 12%, show it is growing at a similar rate (10.5%)
- Camden Health Partners Limited
10.5% - Industry AVG
Production
with a gross margin of 39.9%, this company has a comparable cost of product (39.9%)
- Camden Health Partners Limited
39.9% - Industry AVG
Profitability
an operating margin of 1.3% make it less profitable than the average company (3.7%)
- Camden Health Partners Limited
3.7% - Industry AVG
Employees
with 50 employees, this is above the industry average (23)
50 - Camden Health Partners Limited
23 - Industry AVG
Pay Structure
on an average salary of £34.6k, the company has an equivalent pay structure (£34.6k)
- Camden Health Partners Limited
£34.6k - Industry AVG
Efficiency
resulting in sales per employee of £158.7k, this is more efficient (£86.6k)
- Camden Health Partners Limited
£86.6k - Industry AVG
Debtor Days
it gets paid by customers after 16 days, this is earlier than average (30 days)
- Camden Health Partners Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 177 days, this is slower than average (25 days)
- Camden Health Partners Limited
25 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Camden Health Partners Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 61 weeks, this is more cash available to meet short term requirements (39 weeks)
61 weeks - Camden Health Partners Limited
39 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 75.6%, this is a higher level of debt than the average (55.9%)
75.6% - Camden Health Partners Limited
55.9% - Industry AVG
CAMDEN HEALTH PARTNERS LIMITED financials
Camden Health Partners Limited's latest turnover from March 2024 is estimated at £7.9 million and the company has net assets of £770.5 thousand. According to their latest financial statements, Camden Health Partners Limited has 50 employees and maintains cash reserves of £2.8 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 7,224,228 | 7,482,763 | 5,803,640 | 3,311,742 | 2,461,638 | 1,922,437 | 1,349,346 | 1,396,576 | 1,239,771 | ||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 5,900,973 | 5,981,099 | 4,552,581 | 2,763,497 | 1,951,323 | 1,564,747 | 1,059,866 | 1,038,227 | 905,743 | ||||||
| Gross Profit | 1,323,255 | 1,501,664 | 1,251,059 | 548,245 | 510,315 | 357,690 | 289,480 | 358,349 | 334,028 | ||||||
| Admin Expenses | 1,127,308 | 1,459,959 | 1,269,440 | 590,055 | 437,541 | 426,138 | 350,808 | 295,290 | |||||||
| Operating Profit | 195,947 | 41,705 | -18,381 | -41,810 | 72,774 | -136,658 | 7,541 | 38,738 | |||||||
| Interest Payable | 1,228 | 1,741 | 2,305 | ||||||||||||
| Interest Receivable | 1,035 | 2,547 | 717 | ||||||||||||
| Pre-Tax Profit | 194,719 | 39,964 | -20,686 | -42,444 | 72,774 | 39,737 | -135,623 | 10,088 | 4,555 | ||||||
| Tax | -30,209 | -535 | -151 | ||||||||||||
| Profit After Tax | 164,510 | 39,964 | -20,686 | -42,444 | 72,774 | 39,737 | -135,623 | 9,553 | 4,404 | ||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | 164,510 | 39,964 | -20,686 | -42,444 | 72,774 | 39,737 | -135,623 | 9,553 | 4,404 | ||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | 50 | 43 | 80 | 61 | 35 | 57 | |||||||||
| EBITDA* | 202,379 | 49,393 | -11,846 | -40,734 | 72,774 | -136,658 | 7,541 | 38,738 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 5,822 | 12,254 | 23,139 | 30,827 | 31,082 | ||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 5,822 | 12,254 | 23,139 | 30,827 | 31,082 | ||||||||||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 353,025 | 256,090 | 1,054,718 | 408,503 | 178,371 | 1,311,993 | 1,983,589 | 1,572,478 | 778,356 | 151,104 | 46,839 | 156,638 | 77,650 | 13,879 | |
| Group Debtors | |||||||||||||||
| Misc Debtors | 155,718 | 303,845 | 235,184 | 222,309 | 344,253 | 9,923 | 3,175 | 12,968 | 5,699 | 2,289 | |||||
| Cash | 2,804,711 | 3,104,314 | 1,816,974 | 1,076,071 | 713,162 | 828,580 | 245,801 | 61,847 | 68,125 | 268,426 | 332,396 | 42,325 | 81,824 | 319,392 | 210,367 |
| misc current assets | 16 | ||||||||||||||
| total current assets | 3,157,736 | 3,360,404 | 2,871,692 | 1,484,574 | 1,047,251 | 2,444,434 | 2,464,574 | 1,856,634 | 1,190,734 | 429,453 | 382,410 | 211,931 | 165,173 | 335,560 | 210,367 |
| total assets | 3,157,736 | 3,360,404 | 2,871,692 | 1,484,574 | 1,047,251 | 2,450,256 | 2,476,828 | 1,879,773 | 1,221,561 | 460,535 | 382,410 | 211,931 | 165,173 | 335,560 | 210,367 |
| Bank overdraft | 9,987 | ||||||||||||||
| Bank loan | 11,000 | 11,000 | 11,000 | 11,000 | |||||||||||
| Trade Creditors | 2,324,271 | 2,736,374 | 2,493,614 | 1,422,740 | 179,136 | 1,447,688 | 1,319,505 | 1,009,280 | 323,383 | 82,501 | 67,703 | 472 | 9,925 | 126,890 | 52,600 |
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 62,970 | 47,177 | 56,330 | 914,638 | 900,950 | 876,186 | 741,566 | 795,089 | 242,999 | 195,370 | 164,895 | 148,421 | 87,562 | 60,757 | |
| total current liabilities | 2,387,241 | 2,783,551 | 2,549,944 | 1,422,740 | 1,093,774 | 2,358,625 | 2,206,691 | 1,761,846 | 1,129,472 | 336,500 | 263,073 | 165,367 | 158,346 | 214,452 | 113,357 |
| loans | 11,793 | 24,093 | 35,882 | 47,142 | |||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | 11,793 | 24,093 | 35,882 | 47,142 | |||||||||||
| total liabilities | 2,387,241 | 2,783,551 | 2,549,944 | 1,422,740 | 1,093,774 | 2,358,625 | 2,218,484 | 1,785,939 | 1,165,354 | 383,642 | 263,073 | 165,367 | 158,346 | 214,452 | 113,357 |
| net assets | 770,495 | 576,853 | 321,748 | 61,834 | -46,523 | 91,631 | 258,344 | 93,834 | 56,207 | 76,893 | 119,337 | 46,564 | 6,827 | 121,108 | 97,010 |
| total shareholders funds | 770,495 | 576,853 | 321,748 | 61,834 | -46,523 | 91,631 | 258,344 | 93,834 | 56,207 | 76,893 | 119,337 | 46,564 | 6,827 | 121,108 | 97,010 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 195,947 | 41,705 | -18,381 | -41,810 | 72,774 | -136,658 | 7,541 | 38,738 | |||||||
| Depreciation | 2,233 | 6,432 | 6,432 | 7,688 | 6,535 | 1,076 | |||||||||
| Amortisation | |||||||||||||||
| Tax | -30,209 | -535 | -151 | ||||||||||||
| Stock | |||||||||||||||
| Debtors | 96,935 | -798,628 | 646,215 | 74,414 | -1,281,749 | -602,935 | 423,986 | 672,178 | 961,582 | 111,013 | -119,592 | 86,257 | 67,181 | 16,168 | |
| Creditors | -412,103 | 242,760 | 1,070,874 | 1,243,604 | -1,268,552 | 128,183 | 310,225 | 685,897 | 240,882 | 14,798 | 67,231 | -9,453 | -116,965 | 74,290 | 52,600 |
| Accruals and Deferred Income | 15,793 | -9,153 | 56,330 | -914,638 | 13,688 | 24,764 | 134,620 | -53,523 | 552,090 | 47,629 | 30,475 | 16,474 | 60,859 | 26,805 | 60,757 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | 193,029 | 9,589 | -180,456 | -89,320 | 290,072 | -259,945 | 91,933 | 151,944 | |||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | -11,000 | 11,000 | |||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | -11,793 | -12,300 | -11,789 | -11,260 | 47,142 | ||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | -1,228 | -1,741 | -2,305 | 1,035 | 2,547 | 717 | |||||||||
| cash flow from financing | -13,528 | -15,867 | -13,565 | -1 | 22,377 | 17,092 | 93,323 | ||||||||
| cash and cash equivalents | |||||||||||||||
| cash | -299,603 | 1,287,340 | 740,903 | 362,909 | -115,418 | 582,779 | 183,954 | -6,278 | -200,301 | -63,970 | 290,071 | -39,499 | -237,568 | 109,025 | 210,367 |
| overdraft | -9,987 | 9,987 | |||||||||||||
| change in cash | -299,603 | 1,287,340 | 740,903 | 362,909 | -105,431 | 572,792 | 183,954 | -6,278 | -200,301 | -63,970 | 290,071 | -39,499 | -237,568 | 109,025 | 210,367 |
camden health partners limited Credit Report and Business Information
Camden Health Partners Limited Competitor Analysis
Perform a competitor analysis for camden health partners limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in N12 area or any other competitors across 12 key performance metrics.
camden health partners limited Ownership
CAMDEN HEALTH PARTNERS LIMITED group structure
Camden Health Partners Limited has no subsidiary companies.
Ultimate parent company
CAMDEN HEALTH PARTNERS LIMITED
06584530
camden health partners limited directors
Camden Health Partners Limited currently has 7 directors. The longest serving directors include Dr Alex Warner (May 2022) and Miss Josephine Ohlson (Oct 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Alex Warner | United Kingdom | 44 years | May 2022 | - | Director |
| Miss Josephine Ohlson | United Kingdom | 66 years | Oct 2022 | - | Director |
| Dr Claire Chalmers-Watson | United Kingdom | 57 years | Jan 2023 | - | Director |
| Dr Crenguta Zahan | United Kingdom | 48 years | Jan 2023 | - | Director |
| Dr Stuart MacKay-Thomas | United Kingdom | 50 years | Jan 2023 | - | Director |
| Mr Philip Posner | United Kingdom | 62 years | Apr 2023 | - | Director |
| Ms Diane Pearson | 59 years | Jun 2024 | - | Director |
P&L
March 2024turnover
7.9m
+11%
operating profit
103.1k
0%
gross margin
39.9%
-3.18%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
770.5k
+0.34%
total assets
3.2m
-0.06%
cash
2.8m
-0.1%
net assets
Total assets minus all liabilities
camden health partners limited company details
company number
06584530
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
May 2008
age
17
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
haverstock healthcare limited (December 2020)
accountant
RAMSAY BROWN LLP
auditor
-
address
ramsay brown llp, the brentano suite, north finchley, london, N12 8QJ
Bank
-
Legal Advisor
-
camden health partners limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to camden health partners limited.
camden health partners limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CAMDEN HEALTH PARTNERS LIMITED. This can take several minutes, an email will notify you when this has completed.
camden health partners limited Companies House Filings - See Documents
| date | description | view/download |
|---|
